PepGen (PEPG) director granted stock options for 34,000 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PepGen Inc. director Laurie Keating reported a new compensation award on a Form 4. She received a stock option to buy 34,000 shares of PepGen common stock at an exercise price of $1.79 per share, expiring on June 17, 2036.
The option vests in full on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting, as long as she continues serving as a director, unless the board decides otherwise. After this grant, Keating holds options covering 34,000 underlying shares from this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
KEATING LAURIE
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 34,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 34,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 34,000 shares
Exercise price: $1.79 per share
Expiration date: June 17, 2036
+1 more
4 metrics
Option grant size
34,000 shares
Stock Option (Right to Buy) granted to director
Exercise price
$1.79 per share
Conversion or exercise price of stock option
Expiration date
June 17, 2036
Option expiration for director grant
Shares underlying option
34,000 shares
Underlying common stock covered by option
Key Terms
Stock Option (Right to Buy), exercise price, Annual Meeting, Board of Directors
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual Meeting financial
"earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
Board of Directors financial
"unless the Board of Directors determines that the circumstances warrant continuation of vesting"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What did PepGen (PEPG) director Laurie Keating report in this Form 4?
Laurie Keating reported receiving a stock option grant for 34,000 PepGen shares. The option is a compensation award, not an open‑market trade, and gives her the right to buy common stock at a fixed exercise price of $1.79 per share.
What are the key terms of Laurie Keating’s PepGen stock option grant?
The grant covers 34,000 shares of PepGen common stock at a $1.79 exercise price, expiring June 17, 2036. It is held directly by Keating and represents a right to buy, not an immediate ownership of, the underlying common shares.
How does the PepGen stock option granted to Laurie Keating vest?
The option vests in full on the earlier of the first anniversary of the grant date or the next Annual Meeting. Vesting continues only while she serves as a director, unless the board determines that circumstances justify continued vesting after service ends.
Is Laurie Keating’s PepGen Form 4 a stock purchase or a compensation award?
The Form 4 reflects a compensation award, not an open‑market purchase. Keating received a grant of stock options with a $1.79 exercise price, classified as a grant or award acquisition, giving her the right to buy shares in the future if she chooses.